Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.spandiag.com | |
Market Cap | 8.74 Cr. | |
Enterprise Value(EV) | 18.27 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -6.78 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-09 |
Industry PE | 37.71 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | -5.51 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | -2.90 | Calculated using Price: 16.00 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.55 Cr. | 5,461,747 Shares |
FaceValue | 10 | |
About Span Divergent Ltd. | ||
A thought, conceived more than three decades ago by a pathologist, Dr. Pradip K. Desai, evolved into a start-up company as the Desai Laboratories. The goal was to indigenously develop and manufacture a comprehensive range of ready-made diagnostic reagents needed by clinical pathology laboratories. In 1976, the company was reorganized as Span Diagnostics with an emphasis on in-house R & D to develop more and more products, keeping the customer needs in focus and quality under constant vigil. |
1 Day |
|
-1.42% |
1 Week |
|
-2.91% |
1 Month |
|
-6.43% |
3 Month |
|
+41.97% |
6 Month |
|
+7.38% |
1 Year |
|
+23.93% |
2 Year |
|
+17.73% |
5 Year |
|
-47.11% |
10 Year |
|
-39.85% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 92.48 | 5.87 | -5.29 | -29.53 | -45.78 | -40.14 | -41.61 | -142.60 | ||
Return on Capital Employed (%) | 80.49 | 8.14 | -4.08 | -17.56 | -21.68 | -17.85 | -14.67 | -44.86 | -43.90 | |
Return on Assets (%) | 50.20 | 5.63 | -4.53 | -19.54 | -24.98 | -19.44 | -16.73 | -32.78 | -20.51 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 62 | 50 | 49 | 36 | 25 | 18 | 12 | 2 | -3 | -3 | |
Non Curr. Liab. | 0 | 0 | 7 | 9 | 8 | 11 | 13 | 7 | 6 | 5 | |
Curr. Liab. | 4 | 0 | 9 | 18 | 19 | 15 | 14 | 23 | 28 | 28 | |
Minority Int. | 0 | 0 | -3 | -4 | -5 | -5 | -6 | -6 | |||
Equity & Liab. | 66 | 51 | 65 | 63 | 49 | 39 | 34 | 28 | 25 | 24 | |
Non Curr. Assets | 12 | 13 | 28 | 27 | 24 | 21 | 18 | 16 | 14 | 12 | |
Curr. Assets | 54 | 38 | 37 | 36 | 25 | 18 | 16 | 12 | 12 | 12 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 66 | 51 | 65 | 63 | 49 | 39 | 34 | 28 | 25 | 24 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 76 | 3 | 15 | 24 | 9 | 7 | 13 | 13 | 13 | ||
Other Income | 2 | 3 | 4 | 3 | 1 | 2 | 2 | 3 | 1 | 1 | |
Total Income | 78 | 3 | 7 | 18 | 25 | 12 | 9 | 16 | 13 | 14 | |
Total Expenditure | -74 | -5 | -8 | -25 | -31 | -15 | -10 | -14 | -11 | -12 | |
PBIDT | 3 | -3 | -1 | -7 | -6 | -3 | 0 | 2 | 2 | 2 | |
Interest | -4 | 0 | 0 | -2 | -2 | -2 | -2 | -1 | -1 | -1 | |
Depreciation | -6 | 0 | -1 | -3 | -4 | -3 | -3 | -2 | -2 | -2 | |
Taxation | -6 | -1 | 0 | 0 | -1 | 1 | 0 | 0 | 0 | 0 | |
Exceptional Items | 52 | 7 | -1 | -2 | -1 | -1 | -9 | -4 | -3 | ||
PAT | 39 | 3 | -3 | -13 | -14 | -9 | -6 | -10 | -5 | -4 | |
Minority Interest | 0 | 2 | 1 | 1 | 0 | 0 | 0 | ||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 39 | 3 | -3 | -13 | -12 | -8 | -6 | -10 | -5 | -4 | |
Adjusted EPS | 54 | 6 | -5 | -23 | -22 | -14 | -10 | -18 | -9 | -7 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 8 | 61 | -7 | -5 | -12 | -7 | 0 | 0 | 7 | 2 | |
Cash Fr. Inv. | -5 | -12 | 13 | -6 | 1 | 10 | 6 | 2 | -2 | 1 | |
Cash Fr. Finan. | -4 | -42 | -12 | 13 | 7 | -3 | -7 | -1 | -6 | -2 | |
Net Change | 0 | 7 | -6 | 2 | -4 | 0 | -2 | 0 | -1 | 0 | |
Cash & Cash Eqvt | 1 | 8 | 2 | 5 | 2 | 2 | 0 | 1 | 0 | 0 |
Mon, 04 Dec 2023
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015 With Respect To Change In Address Of Registrar And Transfer Agent Announcement under Regulation 30 of SEBI (LODR) Regulations 2015 with respect to change in Address of Registrar and Transfer Agent of Span Divergent Limited |
Sat, 11 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Span Divergent Limited - Newspaper Publication |
Fri, 10 Nov 2023
Span Divergent Limited-Financial Results For The Quarter And Half Year Ended September 30 2023 With Revised Consolidated Segment Results Span Divergent Limited- Financial Results for the quarter and half year ended September 30 2023 with revised consolidated segment results |
Fri, 08 Dec 2023 |
|
|
|
|
|